P1365Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair

MLA

Sandra Voss, et al. “P1365Evaluation of Cystatin C and NGAL as Predictors of Mortality in Patients Undergoing Percutaneous Mitral Valve Repair.” European Heart Journal, vol. 38, Aug. 2017. EBSCOhost, https://doi.org/10.1093/eurheartj/ehx502.p1365.

APA

Sandra Voss, Helge Moellmann, L. Gaede, Niklas Boeder, Christian Troidl, Claudia Walther, Holger Nef, Kay Weipert, J. Lorenz, Timm Bauer, Christian W. Hamm, M. Ortlieb, O Doerr, & Christoph Liebetrau. (2017). P1365Evaluation of cystatin C and NGAL as predictors of mortality in patients undergoing percutaneous mitral valve repair. European Heart Journal, 38. https://doi.org/10.1093/eurheartj/ehx502.p1365

Chicago

Sandra Voss, Helge Moellmann, L. Gaede, Niklas Boeder, Christian Troidl, Claudia Walther, Holger Nef, et al. 2017. “P1365Evaluation of Cystatin C and NGAL as Predictors of Mortality in Patients Undergoing Percutaneous Mitral Valve Repair.” European Heart Journal 38 (August). doi:10.1093/eurheartj/ehx502.p1365.